Kozlov Yuval

Topical β-blockers for treatment of glaucoma and the risk of Parkinson's disease.

Topical β-blocker use was not associated with an increased risk of PD. These findings suggest that topical β-blockers are a safe therapeutic option, even for patients at potential risk for PD.

Parkinson's disease incidence in glaucoma patients from israel: insights from a 20-year follow-up sample.

This large-scale study found no statistically significant association between glaucoma and the risk of developing PD. These findings suggest that any potential relationship is likely weak and may be influenced by confounding factors.